HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Erik F J de Vries Selected Research

1- O- (4- (2- fluoroethylcarbamoyloxymethyl)- 2- nitrophenyl)- O- glucopyronuronate

3/201218F-FEAnGA for PET of β-glucuronidase activity in neuroinflammation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Erik F J de Vries Research Topics

Disease

27Neoplasms (Cancer)
11/2022 - 01/2002
21Neuroinflammatory Diseases
01/2022 - 09/2006
17Breast Neoplasms (Breast Cancer)
11/2022 - 02/2012
13Inflammation (Inflammations)
11/2021 - 10/2003
7Multiple Sclerosis
01/2022 - 01/2008
4Neoplasm Metastasis (Metastasis)
11/2022 - 10/2013
4Brain Neoplasms (Brain Tumor)
01/2022 - 01/2020
4Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022 - 01/2008
4Disease Progression
01/2017 - 09/2006
4Herpes Simplex Encephalitis (Herpes Encephalitis)
05/2016 - 11/2009
4Demyelinating Diseases (Demyelinating Disease)
10/2014 - 02/2014
3Cognitive Dysfunction
01/2020 - 03/2010
3Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
10/2019 - 08/2014
3Glioma (Gliomas)
01/2018 - 04/2004
3Carcinoma (Carcinomatosis)
04/2017 - 01/2005
3Alzheimer Disease (Alzheimer's Disease)
03/2014 - 10/2003
2Anhedonia
01/2022 - 06/2020
2Melanoma (Melanoma, Malignant)
01/2022 - 12/2021
2Parkinson Disease (Parkinson's Disease)
01/2020 - 01/2008
2Brain Diseases (Brain Disorder)
05/2019 - 03/2014
2Ischemia
01/2019 - 10/2003
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2018 - 07/2004
1Memory Disorders (Memory Loss)
10/2022
1Schizophrenia (Dementia Praecox)
10/2022
1Central Nervous System Diseases (CNS Diseases)
01/2022
1Weight Gain
01/2022
1Neurobehavioral Manifestations
01/2022
1Prostatic Neoplasms (Prostate Cancer)
01/2021
1Body Weight (Weight, Body)
01/2020
1Psychotic Disorders (Schizoaffective Disorder)
01/2020
1Amyloid Plaque
10/2019

Drug/Important Bio-Agent (IBA)

12Estrogen ReceptorsIBA
11/2022 - 02/2012
716-fluoroestradiolIBA
11/2022 - 01/2018
7Glucose (Dextrose)FDA LinkGeneric
10/2022 - 09/2006
7PK 11195 (PK11195)IBA
08/2016 - 01/2008
6Estradiol (Delestrogen)FDA LinkGeneric
11/2022 - 10/2015
6EnzymesIBA
11/2021 - 05/2010
6Proteins (Proteins, Gene)FDA Link
06/2020 - 01/2005
5Pharmaceutical PreparationsIBA
01/2022 - 01/2008
5GlucuronidaseIBA
11/2012 - 05/2010
5ProdrugsIBA
11/2012 - 01/2002
4Biomarkers (Surrogate Marker)IBA
05/2022 - 09/2006
3(R)- (11C)1- (2- chlorophenyl)- N- methyl- N- (1- methylpropyl)- 3- isoquinolinecarboxamideIBA
01/2022 - 01/2017
3N-methyl-4,4'-diaminostilbeneIBA
01/2022 - 02/2014
3Interleukin-2 Receptors (IL 2 Receptor)IBA
12/2021 - 10/2010
3RadiopharmaceuticalsIBA
01/2021 - 10/2010
3Androgen Receptors (Androgen Receptor)IBA
01/2021 - 12/2017
3Estrogens (Estrogen)FDA Link
04/2017 - 03/2014
3Cytostatic AgentsIBA
11/2012 - 03/2010
3GABA-A Receptors (GABA(A) Receptor)IBA
11/2009 - 09/2006
3Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2008 - 10/2003
2Immune Checkpoint InhibitorsIBA
01/2022 - 12/2021
2Interleukin-2 (IL2)IBA
12/2021 - 10/2012
2Brain-Derived Neurotrophic Factor (BDNF)IBA
06/2020 - 05/2019
2Antipsychotic Agents (Antipsychotics)IBA
01/2020 - 10/2014
2Deoxyglucose (2 Deoxy D glucose)IBA
01/2020 - 02/2012
2isoquinolineIBA
01/2020 - 11/2009
2Myelin-Oligodendrocyte GlycoproteinIBA
10/2019 - 08/2014
22- fluoro- 6- (6- hydroxynaphthalen- 2- yl)pyridin- 3- olIBA
11/2017 - 04/2017
2GenisteinIBA
11/2017 - 04/2017
2Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2016 - 04/2004
2Hormones (Hormone)IBA
10/2015 - 03/2014
2Lysophosphatidylcholines (Lysophosphatidylcholine)IBA
10/2014 - 05/2014
2Insulin (Novolin)FDA Link
12/2012 - 11/2012
2LigandsIBA
11/2009 - 01/2008
2TurpentineIBA
01/2008 - 04/2004
16- ((3- cyclobutyl- 2,3,4,5- tetrahydro- 1H- 3- benzazepin- 7- yl)oxy)- N- methyl- 3- pyridinecarboxamideIBA
01/2022
1Antidepressive Agents (Antidepressants)IBA
01/2022
1CorticosteroneIBA
01/2022
1KetamineFDA LinkGeneric
01/2022
1Sucrose (Saccharose)IBA
01/2022
1Histamine AgonistsIBA
01/2022
1Histamine H3 Receptors (Histamine H3 Receptor)IBA
01/2022
1Cyclooxygenase 1IBA
11/2021
1bicalutamide (Casodex)FDA LinkGeneric
01/2021
1Dihydrotestosterone (Androstanolone)IBA
01/2021
1enzalutamideIBA
01/2021
1BMS-986192IBA
12/2020
1AZD 6244IBA
12/2020
1elacestrantIBA
10/2020
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
06/2020
1Harmine (Telepathine)IBA
06/2020
1Cyclin-Dependent Kinases (cdk Proteins)IBA
01/2020
1Haloperidol (Haldol)FDA LinkGeneric
01/2020
1Dopamine (Intropin)FDA LinkGeneric
01/2020
1Cholinergic Agents (Cholinergics)IBA
01/2020
1palbociclibIBA
01/2020
1SodiumIBA
01/2020
1FluoridesIBA
01/2020
1Letrozole (Femara)FDA LinkGeneric
01/2020
1Trastuzumab (Herceptin)FDA Link
01/2020
1RacloprideIBA
01/2020
1incomplete Freund's adjuvantIBA
10/2019
1Freund's AdjuvantIBA
10/2019
1Biological ProductsIBA
05/2019
1Nerve Growth Factors (Neurotrophins)IBA
05/2019

Therapy/Procedure

17Therapeutics
01/2022 - 01/2008
3Immunotherapy
05/2022 - 12/2012
3Radiotherapy
01/2020 - 01/2018
2Drug Therapy (Chemotherapy)
10/2014 - 11/2012